(Q50979269)

26 March 2018

title

Clinical efficacy of dirithromycin in patients with bacteremic pneumonia. (English)

1 reference

26 March 2018

author name string

Hernández JM

1

1 reference

26 March 2018

Sides GD

2

1 reference

26 March 2018

Conforti PM

3

1 reference

26 March 2018

Smietana MG

4

1 reference

26 March 2018

publication date

1 November 1996

1 reference

26 March 2018

published in

Clinical Therapeutics

1 reference

26 March 2018

volume

18

1 reference

26 March 2018

issue

6

1 reference

26 March 2018

page(s)

1128-1138

1 reference

26 March 2018

Aetiology of community acquired pneumonia in Valencia, Spain: a multicentre prospective study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Bacteraemic pneumococcal pneumonia: a continuously evolving disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Steady-state pharmacokinetics of theophylline in COPD patients treated with dirithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

The Influence of Dirithromycin on the Pharmacokinetics of Cyclosporine in Healthy Subjects and in Renal Transplant Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

From the Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Pharmacokinetic drug interactions of macrolides

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Dirithromycin increases ethinyl estradiol clearance without allowing ovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Pharmacokinetics of dirithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Clinical efficacy of dirithromycin in pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Dirithromycin in the treatment of streptococcal pharyngitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Clinical efficacy of dirithromycin in pharyngitis and tonsillitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Dirithromycin in the treatment of skin and skin structure infections

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

A multicentre study comparing the safety and efficacy of dirithromycin with erythromycin in the treatment of bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Tissue distribution of dirithromycin: comparison with erythromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Pulmonary penetration of dirithromycin in patients suffering from acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Modulation of human polymorphonuclear neutrophil function by macrolides: preliminary data concerning dirithromycin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Emergence of drug-resistant pneumococcal infections in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Pneumococcal pneumonia in adult hospitalized patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

Pneumococcal disease and HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2896%2980067-1

7 January 2021

10.1016/S0149-2918(96)80067-1

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018